NASDAQ : AIRS
$0.29 (6.97%)
NASDAQ
Yogi Jashnani
Medical - Care Facilities
Healthcare
AIRS
330
US
USD
0.71
0.75
0.75
0.51
0.00
$151.82M
2.07
3.08
45.20
0.10
-$0.19
-$11.67M
-7.39%
-9.22%
-12.42%
-5.84%
-25.30
-0.82
-0.82
$4.50
$4.50
$4.50
2/5
5 Analysts
-1.11%
About AirSculpt Technologies, Inc. (NASDAQ:AIRS) Stock
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient’s own fat cells to enhance the ... buttocks, breasts, hips, aging hands, or other areas. Further, the company’s body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
2026-06-16 10:00:00
HONG KONG & SEOUL, South Korea--(BUSINESS WIRE)--AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical's next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation. Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (“MRI”) ac.
Is Prisma AIRS Becoming Palo Alto Networks' Fastest Growth Engine?
2026-06-10 11:10:48
Palo Alto Networks is seeing rapid adoption of Prisma AIRS, with customer growth and larger AI security deals boosting its revenue potential.
AirSculpt Technologies Announces Participation in Upcoming Investor Conferences
2026-05-27 16:05:00
MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences.
AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth
2026-05-19 18:16:46
AirSculpt Technologies NASDAQ: AIRS executives said the body contouring company has returned to same-store sales growth after more than two years of declines, while outlining plans to expand services tied to GLP-1 weight-loss drug side effects and eventually resume clinic growth across the U.S.
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
2026-05-12 09:50:46
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
AirSculpt Technologies Q1 Earnings Call Highlights
2026-05-08 16:07:26
AirSculpt Technologies NASDAQ: AIRS reported first-quarter fiscal 2026 results that management characterized as a “key turning point,” citing stabilized revenue, the first positive same-center sales result in more than two years, and continued debt reduction. Get AirSculpt Technologies alerts:Sign UpQ1 results: flat revenue, positive same-center sales, and margin expansion Chief Executive Officer Yogi Jashnani said the company “stabilized revenue year-over-year and delivered positive same-center sales for the first time in over two years,” while also expanding gross margin.
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript
2026-05-08 14:21:15
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
2026-05-08 06:30:00
MIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026.
Frequently Asked Questions
What is the current AirSculpt Technologies, Inc. (AIRS) stock price?
AirSculpt Technologies, Inc.(NASDAQ:AIRS) stock price is $4.45 in the last trading session. During the trading session, AIRS stock reached the peak price of $12 while $1.51 was the lowest point it dropped to. The percentage change in AIRS stock occurred in the recent session was 6.97% while the dollar amount for the price change in AIRS stock was $0.29.
AIRS's industry and sector of operation?
The NASDAQ listed AIRS is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
Who are the executives of AIRS?
Brent R. Wadman
| General Counsel
Michael J. Arthur
| Chief Financial Officer
Stephanie Evans Greene
| Chief Marketing Officer
Yogesh Jashnani
| Chief Executive Officer & Director
|
How many employees does AIRS have?
Number of AIRS employees currently stands at 330. AIRS operates from 1111 Lincoln Road, Miami Beach, FL 33139, US.
Link for AIRS official website?
Official Website of AIRS is: http://www.airsculpt.com
How do I contact AIRS?
AIRS could be contacted at phone #786 709 9690 and can also be accessed through its website. AIRS operates from 1111 Lincoln Road, Miami Beach, FL 33139, US.
How many shares of AIRS are traded daily?
The average number of AIRS shares traded daily for last 3 months was 957.6K.
What is the market cap of AIRS currently?
The market value of AIRS currently stands at $313.93M with its latest stock price at $4.45